A rapid and systematic review of the clinical effectiveness and cost effectiveness of gemcitabine for the treatment of pancreatic cancer

Ward, S., Morris, E., Bansback, N. et al. (4 more authors) (2001) A rapid and systematic review of the clinical effectiveness and cost effectiveness of gemcitabine for the treatment of pancreatic cancer. Technical Report. Core Research , Alton.

Abstract

Metadata

Authors/Creators:
  • Ward, S.
  • Morris, E.
  • Bansback, N.
  • Calvert, N.
  • Crellin, A.
  • Forman, D.
  • Larvin, M.
Copyright, Publisher and Additional Information: Copyright: Queen’s Printer and Controller of HMSO 2001 HTA reports may be freely reproduced for the purposes of private research and study and may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Violations should be reported to hta@soton.ac.uk Applications for commercial reproduction should be addressed to HMSO, The Copyright Unit, St Clements House, 2-16 Colegate, Norwich, NR3 1BQ
Keywords: Clinical effectiveness, Cost effectiveness, Gemcitabine, Pancreatic cancer, Therapy, Treatment, Quality of life, Antineoplastic agents, Cost benefit analysis
Institution: The University of Sheffield, The University of Leeds
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Genetics, Health and Therapeutics (LIGHT) > Division of Epidemiology & Biostatistics (Leeds)
Depositing User: Diana Papaioannou
Date Deposited: 07 Dec 2006
Last Modified: 04 Nov 2016 06:42
Published Version: http://www.hta.ac.uk/1197
Status: Published
Publisher: Core Research
Identification Number: ISSN 1366-5278

Share / Export

Statistics